Abstract:Background The aim of this study was to establish a primary mouse gastric carcinoma cell line. Methods Gastric adenocarcinoma in the body region was induced in immunocompetent BALB/c mice using N-Methyl-N-nitrosourea and a 2% NaCl solution. Fresh gastric cancer tissue samples were cultured in 1640 medium supplemented with 10% fetal bovine serum for primary culture and subculture. Cellular morphology was assessed via light microscopy, and a cell growth curve was established. Genomic and proteomic analyses were conducted to characterize the molecular features of the cell lines. This cell line demonstrated a 100% success rate in forming subcutaneous tumors in BALB/c mice. By integrating proteomic profiles from clinical gastric cancer patients and the murine subcutaneous tumor model, several molecular targets suitable for preclinical investigation were identified. Trametinib, a MEK inhibitor, was employed as a model compound in our preclinical study. Results A novel gastric carcinoma cell line, designated MCC, was established from BALB/c mice. This cell line exhibited a doubling time of approximately 33 hours. Genomic and proteomic analyses identified mutations frequently observed in clinical gastric cancer patients, such as Kras, Egfr, and Ccnd3. Additionally, MCC overexpresses proteins, including SLC1A5, MCC6, and ITGA2, which are significantly upregulated in gastric cancer tissues compared to adjacent non-cancerous tissues. The MCC cell line demonstrated stable tumorigenicity in immunocompetent BALB/c mice, forming subcutaneous tumors that closely resemble the proteomic profile of clinical gastric cancer samples. This high concordance facilitated the identification of several potential therapeutic targets for gastric cancer. Preclinical studies with trametinib revealed that treatment effectively inhibited gastric cancer growth, likely mediated through the activation of immune cells, particularly neutrophils and T cells. Conclusions The MCC cell line is a valuable tool for gastric cancer research, enabling studies of cancer development, progression, and metastasis, and providing a robust platform for evaluating therapeutic strategies and drug efficacy. Its strong tumorigenicity and high correlation with clinical proteomic profiles underscore its relevance in translational research, aiding in the identification of novel therapeutic targets and molecular pathways for effective treatments.

Establishment of Gastric Cancer Model in Nude Mice

Establishment of Nude Mouse Model of Human Prostate Carcinoma by Subcutaneous Injection of Cell Line LNCaP

Establishment and Characterization of a Nude Mouse Model of Subcutaneously Implanted Tumors and Abdominal Metastasis in Gastric Cancer

Establishment and Characterization of a New Mouse Gastric Carcino-Ma Cell Line, MCC

An Establishment of Orthotopic Implant Models for Human Gastric Carcinoma in BNX Mice and Their Biological Properties

Establishment and characterization of human colorectal cancer orthotopic implantation model in nude mice

Establishment of Human Colorectal Cancer Postoperative Metastasis Model in Nude Mice

Establishment of a Highly Metastatic Model of Colorectal Cancer in Mice through in Vivo Selection

Establishment and Comparison of Colon Cancer Liver Metastasis Models in Nude Mice

Establishment of a Transplanted Tumor Model of Human Oral Squamous Cell Carcinoma in Nude Mice

A novel mouse model of gastric cancer with human gastric microenvironment

Establishment of Three Orthotopic Implantation Nude Mice Models of Colorectal Cancer Metastasis to Liver

Establishment of nude mice xenograft tumor models of human endometrial carcinoma in ovariectomized nude mice

The Establishment of a Spontaneous Metastatic Model of Rat Liver Cancer in Nude Mice

Establishment of Postoperative Metastatic Animal Model of Human Glioblastoma in Nude Mice

Establishment of a Metastatic Model of Human Hepatocellular Carcinoma in Nude Mice Via Orthotopic Implantation of Histologically Intact Tissues

Establishment of an orthotopic transplantable gastric cancer animal model for studying the immunological effects of new cancer therapeutic modules

A New Method of Establishing an Orthotopic Murine Bladder Cancer Model

Establishment of nude mice model with human hepatocellular carcinoma multidrug resistance exeografts

The establishment and evaluation of the animal disease model of human endometrial carcinoma in nude rat

Establishment of NOD/SCID Mouse Models of Human Hepatocellular Carcinoma Via Subcutaneous Transplantation of Histologically Intact Tumor Tissue.